Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Bio-Rad Laboratories Inc. Cl A

TRADE

NYSE: BIOHealthcare / Medical Laboratories & Research / USA
305.44-0.95-0.31%Vol 48 2061Y Perf 30.62%
Jul 20th, 2018 16:02
BID289.00 ASK0.00
Open306.84 Previous Close306.39
Pre-Market- After-Trading305.44
 - -%  - -%
Target Price
337.50 
Analyst Rating
Moderate Buy 1.67
Potencial %
10.50 
Finscreener Ranking
★★★★★     62.70
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★★★★     68.65
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★★★     74.44
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)9 102 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
97.78 
Earnings Date
7th Aug 2018

Today's Price Range

305.00307.48

52wk Range

208.95307.63

5 Year PE Ratio Range

18.00288.30

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
1.87%
3 Months
17.17%
6 Months
20.00%
1 Year
30.62%
3 Years
103.56%
5 Years
152.24%

Quotes

Name / TickerPriceChg.Chg.%
BIO305.44-0.9500-0.31
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.60
Current Ratio 4.30
Long Term Debt to Total Capital 0.09
Total Debt to Equity 0.10
Interest Coverage 43.10
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin55.10
EBIT Margin43.60
EBITDA Margin50.30
Pre-tax Profit Margin5.00
Profit Margin44.62
ValuationValueIndustryS&P 500US Markets
PE Ratio 12.00
PB Ratio 2.02
PS Ratios 5.31
Price to Cash Flow 45.70
Price to Free Cash Flow 132.20
Cash Flow Per Share 6.66
Price to Tangible Book2.38
Book Value per Share150.58
Enterprise Value (in ths.)8 632 810
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)3.61
ROE last 12 Months 21.31
Return on Assets (5Y Avg) 1.69
ROA last 12 Months 15.08
Return on Capital (5Y Avg) 3.40
ROC last 12 Months 19.06
Return on invested Capital Q 15.92
Return on invested Capital Y3.89
Assets Turnover0.20
Receivables Turnover1.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1 706 960
Revenue per Share 57.27
Revenue Growth 3 Years -1.05
Revenue Growth 5 Years -0.99
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 20180.901.1730.00
Q04 20171.281.5017.19
Q03 20170.330.91175.76
Q02 20170.630.58-7.94
Q01 20170.270.4151.85
Q04 20161.001.2525.00
Q03 20160.510.6221.57
Q02 20161.130.61-46.02
Earnings Per EndEstimateRevision %Trend
6/2018 QR1.256.84Positive
9/2018 QR1.30-11.56Negative
12/2018 FY6.134.61Positive
12/2019 FY7.600.00-
Next Report Date7th Aug 2018
Estimated EPS Next Report1.35
Estimates Count2
EPS Growth Next 5 Years %15.00
Volume Overview
Volume48 206
Shares Outstanding (in ths.)29 800
Trades Count206
Dollar Volume9 530 694
Avg. Volume152 462
Avg. Weekly Volume72 305
Avg. Monthly Volume111 641
Avg. Quarterly Volume141 251

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

56%44%

Bearish Bullish

62%38%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News

x